Express your opinion about this website:
Traffic report about pulmozyme.com - here you can find answers to questions like these:
Our system has never spotted pulmozyme.com in Alexa ratings.
This fact suggests that domain has very low traffic.
The most recent time we have spotted pulmozyme.com on Quantcast list was on February 6, 2014 (3,742 days ago) and then the rank was 557,073. And this is a bit worse position than average position for pulmozyme.com in Quantcast.
Website is hosted on IP 72.34.128.236.
The host name of this IP address is pulmozyme.com.
There are 1 websites hosted on exact the same IP and 87 websites that are hosted on similar IP address.
We have no data about websites that could be similar to pulmozyme.com.
We've checked pulmozyme.com recently and it was online. The load time was 0.5851 seconds slower than average. The size of document was 27,402 bytes shorter than usually. The website contained 64 links less than the average.
We have no information if pulmozyme.com is optimised for mobile devices.
We did not encounter any safety threats while testing this website.
We did not find any data about pulmozyme.com being listed in the blacklists.
It seems that pulmozyme.com was never dropped before.
Click here to see the list of dropped domains
Our system found out that there could be 291 domains with the same beginning as pulmozyme.com
Our system found out that there could be 815 mistakes made in the typing process.
And here you'll find analysis of HTML code:
PROPERTY | VALUE |
---|---|
Keywords: | pulmozyme, dornase alfa, cystic fibrosis, cystic fibrosis symptoms, mucus in lungs, CF, CF treatment, Genentech, pulmozyme cost, pulmonary function, lung function |
WEB address: | http://pulmozyme.com/ |
Summary: | Find information about cystic fibrosis and Pulmozyme, including how to manage your cystic fibrosis, your CF treatments, and options for financial support. INDICATION Pulmozyme (dornase alfa) is indicated for daily administration along with standard therapies for the management of cystic fibrosis (CF) patients to improve pulmonary function. In CF patients with an FVC ≥ 40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring injectable antibiotics. IMPORTANT SAFETY INFORMATION Pulmozyme should not be used in patients who are allergic to any of its ingredients. Patients may experience the following when using Pulmozyme: change in or loss of their voice, discomfort in the throat, rash, chest pain, red watery eyes, runny nose, lowering of lung function, fever, indigestion, and shortness of breath. There have been no reports of severe allergic reactions caused by the administration of Pulmozyme. Mild to moderate hives and mild skin rash have been observed and have been short-lived. Pediatric Use The safety and effectiveness of Pulmozyme have been established in patients 5 years of age and older. While clinical trial data are limited in patients younger than 5 years of age, the use of Pulmozyme should be considered for pediatric CF patients who may experience potential benefit in lung function or who may be at risk of respiratory tract infection. The safety of Pulmozyme given by daily inhalation for 2 weeks has been studied using 98 CF patients with 65 of them aged 3 months to < 5 years (younger group) and 33 aged 5 years to < 10 years (older group). The PARI BABY™ reusable nebulizer (which uses a face mask instead of a mouthpiece) was used in patients who were unable to show that they could breathe in or out using their mouth throughout the entire treatment period. Overall, the kind of side effects observed in children was similar to those seen in larger trials in older patients. |
<title> | Pulmozyme® (dornase alfa) Cystic Fibrosis Treatment |
Hosting information: | Click here for more hosting information |
Size of HTML code: | -27,402 bytes compared to average |
Total number of links: | -64 links compared to average |
Load time: | +0.58509435 seconds compared to average |
META TAG PROPERTY | VALUE |
Generator | Drupal 7 (http://drupal.org) |
No data about Alexa yet.
This table shows websites that use 72.34.128.236 (pulmozyme.com) for hosting:
List of websites | IP address and hostname |
---|---|
72.34.128.236 pulmozyme.com |
Note: The matching part of IP address is marked with this style.
Website: | pulmozyme.com |
---|---|
Most recent position: | 557,073 reached on February 6, 2014 (3,742 days ago) |
Times found in quant list: | 156 |
Average position: | 586,164 |
All time highest position: | 556,937 reached on February 4, 2014 (3,744 days ago) |
All time lowest position: | 606,663 reached on November 22, 2013 (3,818 days ago) |
There are 291 alternatives to pulmozyme.com
We believe that these mistakes can be made in the typing process of "pulmozyme.com":
No data about pulmozyme.com being in dropped domains database...